Affecting Factors for Chronic Pain After Sternotomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAnkara Etlik City Hospital

About this trial

Chronic pain is common complication of surgery procedures. Rates of mortalits is getting lower in cardiac surgery. This situation has brought us to focus morbidity and long term life quality. Previous study show that chronic pain after cardiac surgery is experienced 11-40% patient. Multifactorial causes play a role in chronic pain etiology. The aim of our study is to determine the causes of chronic pain in patients who underwent sternotomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between the ages of 18-80

BMI 18-35 kg/m2

ASA (American Society of Anesthesiologists) Scoring I-II-III

Elective open coronary artery bypass graft surgery

Disqualifiers

Patients under 18 and over 80 years of age

Patients who do not want to participate in the study

Patients with advanced organ failure (liver failure, renal failure)

Patients with chronic pain or chronic opioid use

Trial population

Patients in the ASA I-II-III risk group, between the ages of 18-80 years, with a BMI between 18-35 kg/m2, who will undergo elective open coronary artery bypass graft surgery, who will undergo elective open heart valve surgery, who will undergo general anesthesia, and who will undergo sternotomy will be included in the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Open cardiac surgery with sternotomy

    Procedure/Surgery

    Factors affecting the occurrence of chronic pain in patients undergoing open cardiac surgery with sternotomy will be investigated.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Self-leeds assessment of neuropathic symptoms and sign findings in 3rd months.

Patients' self-Leeds assessment of neuropathic symptoms and sign (S-LANSS) findings will be evaluated in the 3rd postoperative month. Patients with an S-LANSS score of 12 and above will be diagnosed with chronic neuropathic pain.

Time frame
3rd postoperative month

Secondary outcomes

1

Self-leeds assessment of neuropathic symptoms and sign findings at 6th months

Patients' self-Leeds assessment of neuropathic symptoms and sign (S-LANSS) findings will be evaluated in the 3rd postoperative month. Patients with an S-LANSS score of 12 and above will be diagnosed with chronic neuropathic pain.

Time frame
6th postoperative month
2

Short Form 12 scores in the 3rd month.

Short Form 12 scores will be evaluated in the 3rd month to evaluate the quality of life of the patients.

Time frame
3rd postoperative month
3

Short Form 12 scores in the 6th month.

Short Form 12 scores will be evaluated in the 6th month to evaluate the quality of life of the patients.

Time frame
6th postoperative month
4

Acute pain score

Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be made in 1, 2, 12, 24 hour after extubation in the postoperative period.

Time frame
Up to postoperative 24 hour

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.